OKYO Stock Performance and Moving Averages. In recent trading, OKYO Pharma Ltd (OKYO) stock price has shown some volatility, fluctuating 3.25% over the last five trades and 0.00% ...

Orion Corporation ("Orion"), a globally operating pharmaceutical company, and Invenra Inc., an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today ...

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics ...

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Teva ...

Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

The London-listed pharma company said Thursday that the new deadline for Hookipa to either make an offer for the company or walk away has been extended to Feb. 27. It was previously set for 1700 GMT ...

Health care advocates are supporting legislation to protect access to a federal discount drug program considered critical to community health centers and programs that serve rural and underserved ...

Leerink Partnrs dropped their FY2024 EPS estimates for CVS Health in a report released on Monday, January 27th. Leerink ...

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...

The 340B Drug Pricing Program aims to provide community health care providers an extra tool to generate savings. Legislators ...

The program, called 340b, allows eligible safety net providers to purchase drugs at deeply discounted prices, then reinvest ...